Novo Nordisk SWOT Analysis

Published in Pharma and Healthcare category by MBA Skool Team

Novo Nordisk is one of the leading brands in the pharma and healthcare sector. Novo Nordisk SWOT analysis evaluates the brand by its strengths & weaknesses which are the internal factors along with opportunities & threats which are the external factors. Let us start the SWOT Analysis of Novo Nordisk:

Novo Nordisk Strengths

  1. Deep knowledge about diabetes & experience in its treatment
  2. Free cash flow can be used for expansion, acquisition or R&D
  3. Around 33,000 well trained employees in 75 countries
  4. Wide global footprint(present in 190 countries)
  5. great diversity in senior management teams which is requisite for growth
  6. It was awarded as the most sustainable company in the world

Above are the strengths in the SWOT Analysis of Novo Nordisk. The strengths of Novo Nordisk looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.

Novo Nordisk Weaknesses

  1. Company suffered negative brand image due to its failure to provide information about side effects of Victoza.
  2. Past legal actions have created negative image for company

These were the weaknesses in the Novo Nordisk SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.

Read more about Novo Nordisk

Novo Nordisk Opportunities

  1. Increasing prevalence of diabetes & other chronic ailments due to increasing urbanization & average life expectancy
  2.  Biosimiler market has strong growth opportunities
  3.  Growing numbers of health conscious people

Above we covered the opportunities in Novo Nordisk SWOT Analysis. The opportunities for any brand can include prospects of future growth.

Novo Nordisk Threats

  1. Increasing public debt in European countries
  2. Negative consequences of healthcare reforms in major markets
  3. Stringent healthcare regulations
  4. Increasing pressure in public spending on healthcare due to economic slowdown

The threats in the SWOT Analysis of Novo Nordisk are as mentioned above. The threats for any business can be external factors which can negatively impact its business.

Hence this concludes the Novo Nordisk SWOT analysis.

Continue reading more about the brand/company.

About Novo Nordisk

The table below gives the brand overview along with its target market, segmentation, positioning & USP

Novo Nordisk Overview
Parent Company

Novo Nordisk

Category

Pharmaceutical

Sector

Pharma and Healthcare

Tagline/ Slogan

Changing diabetes

USP

It is leading healthcare company with experience in diabetes treatment &  considerable experience in other area also

Novo Nordisk STP
Segmentation

Diabetes, homeostasis management & hormone replacement therapy

Target Market

Endocrinologists, healthcare professionals providing treatment to patients suffering from diabetes  & other hormonal disorders

Positioning

Novo Nordisk is leading healthcare company with more than 89 years of experience in diabetes treatment.


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Browse marketing analysis of more brands and companies similar to Novo Nordisk. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.

Continue Reading:


The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin